WYMM Tour: Birmingham
October 3 2024, 10:00 AM - 4:45 PM BST
Birmingham, United Kingdom

WYMM Tour: Birmingham

Thursday 3rd October 2024, 10:00 - 17:00 GMT - Birmingham, United Kingdom (timings subject to change)

Generate ultra-rich data for answers with impact.

Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.​​

Join us on Thursday 3rd October 2024 to hear from local experts who are breaking new ground in human genomics, using nanopore technology.​​​

What you're missing matters. Stay on top of what's next.​

Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.

Please note that this is an in-person event.

There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.

Full agenda and venue details coming soon.

Agenda

Birmingham, United Kingdom

10:00 — 17:00 GMT

Agenda (subject to change)

Speaker

10:00 — 10:30

Registration and breakfast​

10:30 — 11:00

Welcome

Rich Compton, Oxford Nanopore Technologies

11:00 — 11:35 ​

The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study

Hannah Titheradge, Clinical Genetics at Birmingham Women's and Children's NHS Foundation Trust, United Kingdom

Lorraine Hartles-Spencer, West Midlands Regional Genetics Lab, United Kingdom

11:35 — 12:00

Towards multi-modal liquid biopsy assays

Florent Mouliere, CRUK National Biomarker Centre, University of Manchester

12:00 — 13:30

Lunch

13:30 — 13:55 ​

Oxford Nanopore Technologies Bioinformatics update

Dan Fordham, Oxford Nanopore Technologies

13:55 — 14:20

Differential isoform regulation in the human brain across regions, development, and between neuropsychiatric disorder cases and controls

Sofia Kudasheva, Earlham Institute

14:20 — 14:45

The era of complete human genomes

Cora Vacher, Oxford Nanopore Technologies

14:45 — 15:45

Networking session

15:45 — 16:15

Panel Q&A session

Moderated by Nirmala Santiapillai, Oxford Nanopore Technologies

16:15 — 16:50

Brain tumour classification using nanopore sequencing

Simon Deacon, University of Nottingham

16:50 — 17:00

Closing remarks

Oxford Nanopore Technologies

17:00 — 20:00

Drinks reception and networking

Speakers

picture of Rich Compton

Welcome

Rich Compton, SVP, Sales & Commercial Operations, Oxford Nanopore Technologies

Richard joined Oxford Nanopore in 2016 to help build our commercial team from scratch. He is now res...

picture of Hannah Titheradge

The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study

Hannah Titheradge, Consultant, Clinical Genetics at Birmingham Women's and Children's NHS Foundation Trust, United Kingdom

Dr. Hannah Titheradge is a Consultant in Clinical Genetics at the Birmingham Women’s and Children’s ...

picture of Lorraine Hartles-Spencer

The NanoporE Enhances Diagnosis in rarE Disease (NEEDED) study

Lorraine Hartles-Spencer, Principal Clinical Scientist, West Midlands Regional Genetics Lab, United Kingdom

Lorraine Hartles-Spencer is currently a Principal Clinical Scientist working within the Birmingham W...

picture of Florent Mouliere

Towards multi-modal liquid biopsy assays

Florent Mouliere, CRUK National Biomarker Centre, University of Manchester

Florent Mouliere leads the Nucleic Acids Biomarker team at the Cancer Research UK National Biomarker...

picture of Dan Fordham

Bioinformatics update

Dan Fordham, Director, Strategic Product Management, EMEA, Oxford Nanopore Technologies

Dr. Dan Fordham is Director, Strategic Product Management EMEA at Oxford Nanopore Technologies focus...

picture of Cora Vacher

The era of complete human genomes

Cora Vacher, Associate Director, Segment Marketing, Oxford Nanopore Technologies

Cora Vacher is the Associate Director of Segment Marketing at Oxford Nanopore Technologies. Cora is ...

picture of Sofia Kudasheva

Differential isoform regulation in the human brain across regions, development, and between neuropsychiatric disorder cases and controls

Sofia Kudasheva, PhD Student, Earlham Institute

Sofia is a fourth year PhD student working in the Haerty lab at the Earlham Institute, UK. Her resea...

picture of Nirmala Santiapillai

Panel Moderator

Nirmala Santiapillai, Oxford Nanopore Technologies

...

picture of Carolyn Tregidgo

Carolyn Tregidgo, VP Applied Development , Oxford Nanopore Technologies

Carolyn Tregidgo is a technical leader with significant experience in DNA sequencing of rare disease...

picture of Simon Deacon

Brain tumour classification using nanopore sequencing

Simon Deacon, University of Nottingham

I am a trainee neuropathologist at Nottingham University Hospitals NHS Trust. I am currently underta...

Resources